Pharmacogenetic prediction for tumor response, toxicity, and survival of NSCLC patients treated with irinotecan and cisplatin chemotherapy

3581 Background: Inherited genetic polymorphisms of the genes involved in the activation and metabolism of irinotecan can affect toxicity and clinical outcome of patients after treatment with irino...